Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 25% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
10 citing papers in PubMed, 20 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors at 3 institutions in 1 country.
Joni M PrasadCancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH 45229.ORCID 0000-0001-5224-6502
Oscar NegrónDepartment of Pathology and Laboratory Medicine, Lineberger Comprehensive Cancer Center, and the UNC Blood Research Center, University of North Carolina, Chapel Hill, NC 27599.ORCID 0000-0002-5234-8397
Xinli DuCancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH 45229.ORCID 0000-0001-8357-8868
Eric S MullinsCancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH 45229.
Joseph S PalumboCancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH 45229.
Jessica M GilbertieDepartment of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27606.
Magnus HöökCenter for Infectious and Inflammatory Diseases, Institute of Biosciences and Technologies, Texas A&M Health Sciences Center, Houston, TX 77030.
Steven P GroverDepartment of Medicine, Lineberger Comprehensive Cancer Center, and the UNC Blood Research Center, University of North Carolina, Chapel Hill, NC 27599.ORCID 0000-0001-8709-8394
Rafal PawlinskiDepartment of Medicine, Lineberger Comprehensive Cancer Center, and the UNC Blood Research Center, University of North Carolina, Chapel Hill, NC 27599.ORCID 0000-0001-5162-7135
Nigel MackmanDepartment of Medicine, Lineberger Comprehensive Cancer Center, and the UNC Blood Research Center, University of North Carolina, Chapel Hill, NC 27599.
Jay L DegenCancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH 45229.ORCID 0000-0003-4160-1382
Matthew J FlickDepartment of Pathology and Laboratory Medicine, Lineberger Comprehensive Cancer Center, and the UNC Blood Research Center, University of North Carolina, Chapel Hill, NC 27599; matthew_flick@med.unc.edu.
Cincinnati Children's Hospital Medical Center · USUniversity of North Carolina at Chapel Hill · USNorth Carolina State University · US
Funding
BINDING OF BACTERIA TO FIBRONECTIN AN FIBRINOGENR01AI020624 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HOOK, AXEL MAGNUS · 1985 to 2020
$9.7M
Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated ThrombosisU01HL143403 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FISHEL, MELISSA L., FLICK, MATTHEW J. · 2018 to 2022
$4.2M
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma diseaseR01CA211098 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FLICK, MATTHEW J. · 2017 to 2022
$2.2M
Mechanisms linking hemostatic factors and neuroinflammatorydiseaseR01NS107258 · NINDS · CINCINNATI CHILDRENS HOSP MED CTR · PI MULLINS, ERIC S · 2019 to 2023
$2.1M
Hemostatic Factors as Determinants of Bacterial Virulence and Host Defense.R01HL085357 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI DEGEN, JAY L · 2006 to 2010
$1.8M
Coagulation factors as modifiers of the colon cancer microenvironmentR01CA204058 · NCI · CINCINNATI CHILDRENS HOSP MED CTR · PI PALUMBO, JOSEPH S. · 2016 to 2020
$1.8M
Hemostatic Factors Drive Prostate Cancer PathogenesisR01CA193678 · NCI · CINCINNATI CHILDRENS HOSP MED CTR · PI PALUMBO, JOSEPH S. · 2016 to 2020
$1.8M
Fibrin(ogen) control of metabolic inflammation and obesityR01DK112778 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FLICK, MATTHEW J. · 2019 to 2022
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Host fibrinogen drives antimicrobial function in · full record | OpenQuestion